- Home
- SBFM vs FTEL Comparison
SBFM vs FTEL Comparison
Compare SBFM & FTEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- FTEL
- Stock Information
- Founded
- SBFM 2006
- FTEL 2007
- Country
- SBFM United States
- FTEL Australia
- Employees
- SBFM N/A
- FTEL N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- FTEL
- Sector
- SBFM Health Care
- FTEL
- Exchange
- SBFM Nasdaq
- FTEL Nasdaq
- Market Cap
- SBFM 4.9M
- FTEL 9.6M
- IPO Year
- SBFM N/A
- FTEL 2023
- Fundamental
- Price
- SBFM $1.23
- FTEL $0.52
- Analyst Decision
- SBFM Strong Buy
- FTEL
- Analyst Count
- SBFM 1
- FTEL 0
- Target Price
- SBFM $15.00
- FTEL N/A
- AVG Volume (30 Days)
- SBFM 790.9K
- FTEL 102.7K
- Earning Date
- SBFM 05-19-2025
- FTEL 05-20-2025
- Dividend Yield
- SBFM N/A
- FTEL N/A
- EPS Growth
- SBFM N/A
- FTEL N/A
- EPS
- SBFM N/A
- FTEL N/A
- Revenue
- SBFM $34,874,283.00
- FTEL $4,990,695.00
- Revenue This Year
- SBFM $192.48
- FTEL N/A
- Revenue Next Year
- SBFM N/A
- FTEL N/A
- P/E Ratio
- SBFM N/A
- FTEL N/A
- Revenue Growth
- SBFM 44.75
- FTEL 29.02
- 52 Week Low
- SBFM $1.17
- FTEL $0.43
- 52 Week High
- SBFM $23.20
- FTEL $49.50
- Technical
- Relative Strength Index (RSI)
- SBFM 37.73
- FTEL 38.58
- Support Level
- SBFM $1.24
- FTEL $0.61
- Resistance Level
- SBFM $1.45
- FTEL $0.55
- Average True Range (ATR)
- SBFM 0.12
- FTEL 0.06
- MACD
- SBFM 0.01
- FTEL 0.04
- Stochastic Oscillator
- SBFM 15.38
- FTEL 53.65
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About FTEL Fitell Corporation
Fitell Corp engages in primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiaries. It operates in two segments: online fitness equipment distribution and licensing business to service the large and growing boutique fitness sector of the broader health and fitness club industry. The majority fitness equipment business is conducted in Australia via its own e-commerce platform and, through third-party sites. Licensing service offers a turnkey solution for personal training studios and commercial gym chains. The company earns maximum of revenue for retail.